aztreonam ( azt , azactam ) was given to 176 patients with complicated urinary tract infections ( uti ) , of whom 110 cases satisfied with the `` '' criteria of uti committee for the evaluation of drug efficacy in the uti ( 3rd ed . ) '' '' , which was modified by adopting the midstream urine data in cases of women .
C0004521
azt
C0699281
azactam